177Lu-Labeled Magnetic Nano-Formulations: Synthesis, Radio- and Physico-Chemical Characterization, Biological Applications, Current Challenges, and Future Perspectives
Molecules · 2025
DOI: 10.3390/molecules30214290 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Eleftherios Halevas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biosciences & Applications, National Centre for Scientific Research "Demokritos", 15310 Athens, Greece. Hauptthemen laut MEDLINE: Lutetium, Radioisotopes, Radiopharmaceuticals, Magnetite Nanoparticles. Die Arbeit nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon WIDERA Programme.
Abstract (Originalsprache)
The advent of nanotechnology has revolutionized the field of medicine, particularly in the development of targeted therapeutic strategies. Among these, radiolabeled nanomaterials have emerged as promising tools for both diagnostic and therapeutic applications, offering precise delivery of radiation to diseased tissues while minimizing damage to healthy ones. Notably, Lutetium-177 (177Lu) has gained significant attention due to its favorable emission properties and availability that render it suitable for imaging and therapeutic purposes. When integrated with magnetic nano-formulations, 177Lu-labeled systems combine the benefits of targeted radiation therapy (TRT) with the unique properties of magnetic nanoparticles (MNPs), such as magnetic resonance imaging (MRI) contrast enhancement and magnetically guided drug delivery to address challenges in diagnosis and treatment of diseases, such as cancer. By examining the latest advancements in their design, particularly surface functionalization and bioconjugation strategies, this study aims to highlight their efficacy in targeted therapy, imaging, and theranostic applications. Furthermore, we discuss the current challenges, such as scalability, biocompatibility, and regulatory hurdles, while proposing future directions to enhance their clinical translation. This comprehensive review underscores the transformative potential of 177Lu-labeled magnetic nano-formulations in precision medicine and their role in shaping the future of therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biosciences & Applications, National Centre for Scientific Research "Demokritos", 15310 Athens, Greece.
- Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Laboratory of Inorganic Chemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Eleftherios Halevas, Despoina Varna
Förderung
- European Union’s Horizon WIDERA Programme
Zitieren
APA
Halevas, E., & Varna, D. (2025). 177Lu-Labeled Magnetic Nano-Formulations: Synthesis, Radio- and Physico-Chemical Characterization, Biological Applications, Current Challenges, and Future Perspectives. Molecules. https://doi.org/10.3390/molecules30214290
Vancouver
Halevas E, Varna D. 177Lu-Labeled Magnetic Nano-Formulations: Synthesis, Radio- and Physico-Chemical Characterization, Biological Applications, Current Challenges, and Future Perspectives. Molecules. 2025. doi:10.3390/molecules30214290
BibTeX
@article{Halevas2025,
author = {Halevas, Eleftherios and Varna, Despoina},
title = {177Lu-Labeled Magnetic Nano-Formulations: Synthesis, Radio- and Physico-Chemical Characterization, Biological Applications, Current Challenges, and Future Perspectives},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30214290}
}
EUVIMED